Why Continuous Monitoring Matters for Neurological Trials

Why Continuous Monitoring Matters for Neurological Trials Parkinson’s and Alzheimer’s diagnoses are increasing as populations age, yet neurological trials face some of the toughest operational challenges in clinical research. Slow disease progression means that many trials run for years, creating a patient retention problem in a population already managing mobility limitations and cognitive decline. Continuous monitoring offers a way to ease the burden of neurological trials by enabling hybrid and decentralized trial designs, supplying objective data between clinical visits, and reducing how o